PI4K

Phosphatidylinositol 4-kinases (PI4Ks) catalyze the synthesis of phosphatidylinositol 4-phosphate (PI4P), an important intermediate for the synthesis of membrane polyphosphoinositides, regulators of multiple cellular functions. PI4P defines the membranes of Golgi and trans-Golgi network (TGN) and regulates trafficking to and from the Golgi. Based on enzymatic differences, two classes of PI4K have been distinguished termed Types II (PI4KII) and III (PI4KIII), and each of which contains α and β isoforms. PI4KII alpha and beta have similar biochemical properties. PI4KIIIs (α- and β-forms) are soluble enzymes structurally related to PI3-kinases, and sensitive to PI3-kinase inhibitors, such as Wortmannin. PI4KIIs produce PtdIns 4-phosphate, an early key signaling molecule in phosphatidylinositol cycle, which is indispensable for T cell activation. PI4KIIIs plays a key role in the production of replication complexes (viral factories) of a number of positive-sense RNA viruses and represents a potential target for novel pan-viral therapeutics.

Cat. No.	Product name	CAS No.	Purity
T16967	T-00127_HEV1	900874-91-1	98%
T16967	T-00127_HEV1 is an inhibitor of phosphatidylinositol 4-kinase III beta (IC50: 60 nM).
T16530	BF738735	1436383-95-7	98%
T16530	BF738735 is an inhibitor of phosphatidylinositol 4-kinase III beta (IC50: 5.7 nM).
T19840	GSK-F1	1402345-92-9	98%
T19840	GSK-F1 is a novel potent PI4KA inhibitor.
T10804	CHMFL-PI3KD-317	2244992-76-3	98%
T10804	CHMFL-PI3KD-317 is a highly potent, selective and orally active PI3Kδ inhibitor, with an IC50 of 6 nM, and exhibits over 10-1500 fold selectivity over other clas...
T12454	PI-273	925069-34-7	98%
T12454	PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KIIα, Inhibits the Growth of Breast Cancer Cells
T12469	PI4KIIIbeta-IN-9	1429624-84-9	98%
T12469	PI4KIIIbeta-IN-9 is a potent inhibitor of PI4KIIIβ(IC50 of 7 nM). .
T26698	AZ044	1800017-49-5	98%
T26698	AZ044 is a potent, selective inhibitor of type III phosphatidylinositol-4-kinase alpha-subtype (PI4KIIIalpha).
T16125	MMV390048	1314883-11-8	98%
T16125	MMV390048 is an antimalarial agent and is a representative of a new chemical class of Plasmodium PI4K inhibitor (Kdapp=0.3 µM). MMV390048 binds to the ATP bindin...
T5421	KDU691	1513879-19-0	98%
T5421	KDU691 is a PI4K inhibitor.
T27499	GSK-A1	1416334-69-4	98%
T27499	GSK-A1 is a novel potent PI4KA inhibitor.
T4220	BQR-695	1513879-21-4	98%
T4220	BQR-695 is a phosphatidylinositol 4-kinase (PI4K) inhibitor with IC50s of 80 and 3.5 nM for human PI4KIIIβ and Plasmodium variant of PI4KIIIβ, respectively.
T13246	UCT943	1450666-80-4	98%
T13246	UCT943 is an inhibitor of Plasmodium falciparum PI4K (IC50 = 23 nM).
T67837	GSK-F1	1384097-27-1	98%
T67837	GSK-F1 is a selective small molecule inhibitor of Type III Phosphatidylinositol 4‑Kinase Alpha (PI4KIIIα), pIC50=8.3.
T2616	PIK-93	593960-11-3	98%
T2616	PIK-93 is the first potent, synthetic PI4K inhibitor with IC50 of 19 nM; inhibits PI3Kα with IC50 of 39 nM.
T12468	PI4KIIIbeta-IN-10	1881233-39-1	98%
T12468	PI4KIIIbeta-IN-10 is a potent inhibitor of PI4KIIIβ (IC50 of 3.6 nM).
T15789	LTURM34	1879887-96-3	98%
T15789	LTURM34 is an inhibitor of DNA-PK with IC50 of 34 nM. LTURM34 displays effective antiproliferative activity in a wide range of tumor cell lines. LTURM34 shows 17...
TQ0009	UCB9608	1616413-96-7	98%
TQ0009	UCB9608 is a selective and orally active PI4KIIIβ inhibitor (IC50: 11 nM), selective over PI3KC2 α, β, and γ lipid kinases.